Amdocs Limited (NASDAQ:DOX) Shares Sold by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC trimmed its stake in Amdocs Limited (NASDAQ:DOXFree Report) by 35.1% during the third quarter, Holdings reports. The fund owned 3,239 shares of the technology company’s stock after selling 1,754 shares during the period. Commonwealth Equity Services LLC’s holdings in Amdocs were worth $274,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Foster & Motley Inc. increased its stake in Amdocs by 0.5% during the second quarter. Foster & Motley Inc. now owns 25,526 shares of the technology company’s stock worth $2,523,000 after purchasing an additional 128 shares during the period. Janney Montgomery Scott LLC lifted its holdings in Amdocs by 1.4% during the 2nd quarter. Janney Montgomery Scott LLC now owns 9,463 shares of the technology company’s stock worth $935,000 after buying an additional 135 shares in the last quarter. Johnson Investment Counsel Inc. boosted its position in Amdocs by 0.9% in the 2nd quarter. Johnson Investment Counsel Inc. now owns 16,144 shares of the technology company’s stock valued at $1,596,000 after buying an additional 142 shares during the period. PFG Advisors grew its stake in shares of Amdocs by 4.8% in the third quarter. PFG Advisors now owns 3,402 shares of the technology company’s stock worth $287,000 after acquiring an additional 155 shares in the last quarter. Finally, Vanguard Personalized Indexing Management LLC increased its position in shares of Amdocs by 3.8% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 4,615 shares of the technology company’s stock worth $456,000 after acquiring an additional 169 shares during the period. Hedge funds and other institutional investors own 90.58% of the company’s stock.

Amdocs Stock Performance

Shares of DOX opened at $92.67 on Wednesday. The company has a quick ratio of 1.41, a current ratio of 1.41 and a debt-to-equity ratio of 0.22. Amdocs Limited has a 52-week low of $78.38 and a 52-week high of $99.75. The stock has a 50 day moving average price of $87.94 and a 200 day moving average price of $86.75. The company has a market capitalization of $10.87 billion, a price-to-earnings ratio of 20.69, a price-to-earnings-growth ratio of 1.50 and a beta of 0.65.

Amdocs (NASDAQ:DOXGet Free Report) last posted its earnings results on Monday, November 6th. The technology company reported $1.42 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.14. Amdocs had a net margin of 11.06% and a return on equity of 17.77%. The firm had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.25 billion. During the same period last year, the firm posted $1.17 EPS. The company’s revenue was up 6.6% on a year-over-year basis. Research analysts predict that Amdocs Limited will post 5.86 EPS for the current fiscal year.

Amdocs Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were given a dividend of $0.435 per share. This represents a $1.74 dividend on an annualized basis and a dividend yield of 1.88%. The ex-dividend date of this dividend was Thursday, December 28th. Amdocs’s dividend payout ratio (DPR) is currently 38.84%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on DOX. Citigroup boosted their target price on Amdocs from $96.00 to $104.00 and gave the stock a “buy” rating in a research note on Wednesday, January 17th. Jefferies Financial Group began coverage on Amdocs in a research report on Friday, December 1st. They set a “buy” rating and a $105.00 price objective for the company. Finally, cut shares of Amdocs from a “strong-buy” rating to a “buy” rating in a report on Wednesday, January 17th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $107.17.

Check Out Our Latest Report on Amdocs

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Read More

Want to see what other hedge funds are holding DOX? Visit to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOXFree Report).

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with's FREE daily email newsletter.